Boehringer Ingelheim Acquires Amal Therapeutics
Boehringer Ingelheim acquired Amal Therapeutics for $365.9M. View deal terms, timeline, and press on Fsome.
Deal Details
- Acquirer
- Boehringer Ingelheim
- Acquired Company
- Amal Therapeutics
- Price
- $365.9M
- Acquisition Type
- Acquisition
- Announced
- July 15, 2019
Canonical: https://fsome.com/acquisitions/boehringer-ingelheim-acquires-amal-therapeutics-8148474 · For the full deal terms, timeline, and press references, please enable JavaScript.